Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study.

Biomedical journal·2020

Same author

Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer.

Endocrine-related cancer·2019

Same author

Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry.

Journal of the Formosan Medical Association = Taiwan yi zhi·2019

Same author

Diagnostic pitfalls and therapeutic outcomes of the macrofollicular variant of papillary thyroid carcinoma.

Biomedical journal·2019

Same author

A registry of acromegaly patients and one year following up in Taiwan.

Journal of the Formosan Medical Association = Taiwan yi zhi·2019

Same author

Frailty and health care use among community-dwelling older adults with diabetes: a population-based study.

Clinical interventions in aging·2018

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Papillary thyroid carcinoma with lymph node metastases.

¹Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taiwan, People's Republic of China. einjd@adm.cgmh.org.tw

Growth Factors (Chur, Switzerland)

|April 25, 2007

Summary

Papillary thyroid cancer (PTC) spreads mainly through lymph node (LN) metastases. Understanding these mechanisms and risk factors is crucial for effective treatment and preventing recurrence in high-risk patients.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Related Experiment Videos

Last Updated: Jul 15, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Area of Science:

Oncology
Cell Biology
Medical Research

Background:

Papillary thyroid cancer (PTC) is the most common type of thyroid cancer.
Lymph node (LN) metastases are the primary route of PTC spread.
Mechanisms of local invasion, LN, and distant metastases in PTC require further investigation.

Purpose of the Study:

To explore the mechanisms of lymphogenous metastasis in papillary thyroid cancer.
To identify key factors predicting lymph node metastasis in PTC.
To evaluate potential therapeutic strategies for blocking lymphogenous spread.

Main Methods:

Review of current literature on PTC metastasis.
Analysis of factors associated with lymph node involvement (vascular invasion, gender, tumor capsule, perithyroid involvement).
Discussion of diagnostic imaging modalities for LN metastases (ultrasonography, PET).
Exploration of gene transfer therapy (sVEGFR3-Fc) for blocking metastasis.

Main Results:

Vascular endothelial growth factor (VEGF)-C and -D promote lymphatic endothelial cell proliferation and new lymphatic vessel growth.
Predictive factors for LN metastases include vascular invasion, male gender, absence of tumor capsule, and perithyroid involvement.
Tumor recurrence in LNs negatively impacts survival, especially in patients over 45.
Gene transfer of sVEGFR3-Fc shows potential for blocking lymphogenous metastasis.

Conclusions:

Aggressive surgical approaches and radioactive iodine therapy are recommended for high-risk PTC patients to minimize LN recurrence.
Understanding metastasis mechanisms can guide targeted therapies.
Early diagnosis and risk factor assessment are vital for patient outcomes.